BiotechTube
Home/Blaze Bioscience/Kristi Harrington, MD, PhD
KH

Kristi Harrington, MD, PhD

SVP of Clinical

Blaze Bioscience

Therapeutic Areas

Oncology

Blaze Bioscience Pipeline

DrugIndicationPhase
Tozuleristide (BLZ-100)Brain Cancer (Pediatric Glioma)Phase 2

Leadership Team at Blaze Bioscience

SD
Steven Daly, MS, MBA
President and CEO
ML
Mila Lobanova, MBA, CPA
EVP of Finance and Operations
JK
Jennifer K. Johnson, MS, JD
SVP of Legal and Intellectual Property
JO
James Olson, MD, PhD
Scientific Founder and Key Advisor
View full Blaze Bioscience profile